Logotype for Uniphar plc

Uniphar (UPR) investor relations material

Uniphar H1 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Uniphar plc
H1 2025 earnings summary2 Sep, 2025

Executive summary

  • Achieved €1.5 billion revenue, €219.7 million gross profit, and €57.5 million EBITDA in H1 2025, with all divisions contributing to organic growth.

  • Adjusted EPS grew 21% year-over-year, supported by a €35 million share buyback and interim dividend increase.

  • ROCE reached 15.5%, exceeding the 12–15% target range.

  • Continued strategic investments in technology, infrastructure, and people to support medium-term €200 million EBITDA target.

  • Maintained strong sustainability performance, with AAA MSCI ESG rating and top-10 global healthcare ESG ranking.

Financial highlights

  • Organic gross profit growth of 8.1% across all divisions; revenue up 8.6% year-over-year to €1,485.5 million.

  • EBITDA increased 2.9% to €57.5 million; organic EBITDA up 4.9%.

  • Adjusted EPS at 9.8 cents, up 21%; free cash flow conversion at 35.3%.

  • Net bank debt at €197.5 million; leverage at 1.9x net bank debt/EBITDA.

  • Gross margin at 14.8%, EBITDA margin at 3.9%.

Outlook and guidance

  • Targeting €200 million EBITDA by 2028, with at least 80% of growth expected to be organic.

  • Free cash flow conversion expected to reach 60–70% by 2028.

  • Net bank debt/EBITDA not to exceed 2.5x in the medium term.

  • Progressive dividend policy and continued share buybacks subject to market conditions.

  • Organic EBITDA acceleration expected in H2 due to revenue phasing and investment timing.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Uniphar earnings date

Logotype for Uniphar plc
H2 202524 Feb, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Uniphar earnings date

Logotype for Uniphar plc
H2 202524 Feb, 2026

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Uniphar Public Limited Company is a diversified healthcare services provider, operating mainly in the Republic of Ireland, the United Kingdom, and on an international scale. The company functions through three primary divisions: Commercial & Clinical, Product Access, and Supply Chain & Retail. In the Commercial & Clinical segment, Uniphar offers outsourced sales, marketing, and multichannel account management services to pharmaco-medical manufacturers, alongside distribution and support services to medical device manufacturers. The Product Access division delivers services that facilitate access to pharmaco-medical products and treatments, establishing vital connections between manufacturers and healthcare stakeholders, as well as providing bespoke distribution partnerships for pharmaceutical partners. The Supply Chain & Retail division is involved in the pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons, and operates a network of pharmacies under various brands. Additionally, it provides a range of support services including pharmacy support, specialist nursing, infusion, medical device distribution, healthcare technology, data intelligence, consultancy, pharmaceutical advisory, medical affairs, online pharmacy, and product fostering services. The company is headquartered in Dublin, Ireland, and its shares are listed on the Irish Stock Exchange.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage